Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Restructuring Costs (2024 - 2025)

Coya Therapeutics (COYA) has disclosed Restructuring Costs for 2 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs rose 49.66% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, up 20.27% year-over-year, with the annual reading at $5.5 million for FY2025, 20.27% up from the prior year.
  • Restructuring Costs hit $1.5 million in Q4 2025 for Coya Therapeutics, up from $1.2 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.5 million in Q2 2025 to a low of $991941.0 in Q4 2024.